evenfolioETF Details
iShares·Health·IHE · NYSE Arca
iShares U.S. Pharmaceuticals ETF (IHE)
- Price
- $107.61
- —30 Oct 2026
- Assets
- $1.6B
- Total net assets
- Expense ratio
- 0.37%
- Category 1.00%
- Yield
- 1.43%
- Trailing distributions
- 1Y return
- 45.3%+16.5%
- Category 28.8%
- 3Y CAGR
- 26.4%+4.8%
- Category 21.5%
- 5Y CAGR
- 13.3%+9.2%
- Category 4.1%
Loading NAV history…
iShares U.S. Pharmaceuticals ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +7.1% | +6.2% | +23.0% | +28.0% | +45.3% | +26.4% | +13.3% | +10.5% | +11.1% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +3.4% | -3.7% | 0.0% | +7.6% | +16.5% | +4.8% | +9.2% | -0.3% | -0.5% |
Holdings
The 10 largest positions make up 78.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 23.51% |
| JNJ | Johnson & Johnson | 22.64% |
| PFE | Pfizer Inc | 4.69% |
| VTRS | Viatris Inc | 4.55% |
| MRK | Merck & Co Inc | 4.50% |
| BMY | Bristol-Myers Squibb Co | 4.43% |
| RPRX | Royalty Pharma PLC Class A | 4.40% |
| ZTS | Zoetis Inc Class A | 4.35% |
| JAZZ | Jazz Pharmaceuticals PLC | 3.36% |
| ELAN | Elanco Animal Health Inc | 2.50% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 26.3
- P/B
- 5.0
- P/S
- 4.3
- P/CF
- 16.9
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
- Cash0.1%
ETF details
- Issuer
- iShares
- Category
- Equity · Health
- Ticker
- IHE
- Exchange
- NYSE Arca
- Inception
- 1 May 2006 (20.5 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.37% (category 1.00%)
- Holdings turnover
- 29% (category 51%)
- Distribution yield
- 1.43%
- Beta, 3 years
- 0.50
- Total net assets
- $1.6B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- IHF · iShares U.S. Healthcare Providers ETFiShares · $1.4B · ER 0.37%5Y 2.5%
- FXH · First Trust Health Care AlphaDEX FundFirst Trust · $1.1B · ER 0.61%5Y 3.0%
- FTXH · First Trust Nasdaq Pharmaceuticals ETFFirst Trust · $1.1B · ER 0.60%5Y 12.6%
- PBPH · Portfolio Building Block World Pharma and Biotech Index ETFPortfolio Building Block ETFs · $1B · ER 0.13%
- PPH · VanEck Pharmaceutical ETFVanEck · $1B · ER 0.36%5Y 11.8%
- RSPH · Invesco S&P 500 Equal Weight Health Care ETFInvesco · $882.1M · ER 0.40%5Y 5.9%